Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors

Published:2020-01 Issue: Volume:178 Page:112959
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Goh Byoungsook,Choi Jieun,Kang Jung-Ah,Park Sung-Gyoo,Seo Jiwon,Kim Tae-Young

Funder

National Research Foundation of Korea

Korea Health Technology R&D Project

Korea Health Industry Development Institute

Ministry of Health & Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference32 articles.

1. Global Hepatitis Report;World Health Organization,2017

2. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?;Alonso;BMC Gastroenterol.,2017

3. Hepatocellular carcinoma. A worldwide problem and the major risk factors;Simonetti;Dig. Dis. Sci.,1991

4. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;Marcellin;N. Engl. J. Med.,2004

5. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial;Janssen;Lancet,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis;International Journal of Molecular Sciences;2023-03-04

2. Structural insights into the HBV receptor and bile acid transporter NTCP;Nature;2022-05-17

3. Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening;Viruses;2021-07-29

4. Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids;Scientific Reports;2020-12

5. Role of Nucleic Acid Polymers and Entry Inhibitors in Functional Cure Strategies for HBV;Current Hepatology Reports;2020-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3